Fernando M. Rodrigues - Nov 29, 2024 Form 4 Insider Report for Teladoc Health, Inc. (TDOC)

Role: President of BetterHelp
Signature: /s/ Adam C. Vandervoort, Attorney-in-Fact
Stock symbol: TDOC
Transactions as of: Nov 29, 2024
Transactions value $: -$249,903
Form type: 4
Date filed: 12/3/2024, 05:26 PM
Previous filing: Sep 27, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TDOC	Common Stock	Options Exercise		+22K			22K	Nov 29, 2024	Direct	F1
transaction	TDOC	Common Stock	Sale	-$93.9K	-7.87K	-35.85%	$11.93	14.1K	Dec 2, 2024	Direct	F2
transaction	TDOC	Common Stock	Sale	-$156K	-14.1K	-100%	$11.07	0	Dec 3, 2024	Direct	F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TDOC	Restricted Stock Units	Options Exercise	$0	-22K	-33.33%	$0.00	43.9K	Nov 29, 2024	Common Stock	22K		Direct	F1, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
F2	Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards.
F3	Represents the weighted average price of transactions ranging from $11.07 to $11.085, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 3 to this Form 4.
F4	On December 1, 2023, the reporting person was granted 65,894 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.